TRAVIS SCOTT: Open Payments
NPI 1225528441 · OWOSSO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,395 in 73 payments from 24 companies in 2025. Trend: 2023 $917 · 2024 $1,092 · 2025 $1,395
Food & beverage: $1,395
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $147 |
| PFIZER INC. | 7 | $144 |
| Lilly USA, LLC | 7 | $136 |
| Novartis Pharmaceuticals Corporation | 5 | $128 |
| Amgen Inc. | 6 | $107 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
| Corcept Therapeutics | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| ABBVIE INC. | 3 | $54 |
Products named: LEQVIO, MOUNJARO, ELIQUIS, REXULTI, Korlym, JARDIANCE, Rybelsus, EVENITY.
Industry payments across MI — which companies pay providers there.
